The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer. (Q43152544)

From Wikidata
Jump to: navigation, search
scientific article published on 23 February 2010
edit
Language Label Description Also known as
English
The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.
scientific article published on 23 February 2010

    Statements

    The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer. (English)
    D Ross Camidge
    Henk M W Verheul
    Roshan Agarwal
    Debashis Sarker
    Stan B Kaye
    Ingrid M E Desar
    Johanna N H Timmer-Bonte
    S Gail Eckhardt
    Karl D Lewis
    Kathryn H Brown
    Mireille V Cantarini
    Clive Morris
    Sarah M A George
    Paul D Smith
    Carla M L van Herpen
    23 February 2010
    1613-1623

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit